Search

Michelle E Hasse

from Elkhart, IN
Age ~32
Get Report
Also known as:
Michelle Elizabeth Hasse
Related to:
Joshua A Richmond, 40Thomas S RichmondSarah K Hasse, 39Mark A Hasse, 70Kevin D Hasse, 67Jeremy L Hasse, 41Ellen M Hasse, 64
Connected to:
Amanda L Hasse, 45Bernard W Hasse, 69Carsten O Hasse, 46Heather R Hasse, 47Janet M Hasse, 90Joel M Hasse, 36Kendall A Hasse, 51Kreg R Hasse, 49Kristina M Hasse, 35Melanie K Hasse, 62

Michelle Hasse Phones & Addresses

  • Elkhart, IN
  • Eau Claire, MI
  • Nappanee, IN
  • Evanston, IL
  • Milwaukee, WI

Work

Company: Thrive medical device consulting Jan 2018 Position: Independent consultant

Education

Degree: Master of Science, Masters School / High School: Northwestern University 2014 to 2015 Specialities: Biotechnology

Skills

Cell Culture • Pcr • Teamwork • Immunohistochemistry • Research • Cell Biology • Western Blotting • Public Speaking • U.s. Food and Drug Administration • Clinical Trials • Trials • Life Sciences • Medical Devices • Medical Surgical • Grant Writing • Communication • Product Development • Clinical Research • Data Analysis • Good Clinical Practice • Ce Marking • Iso 13485 • Project Management • Microsoft Office • Microsoft Word • Microsoft Powerpoint • Microsoft Excel

Industries

Medical Devices

Resumes

Resumes

Michelle Hasse Photo 1

Independent Consultant

View page
Location:
Chicago, IL
Industry:
Medical Devices
Work:
Thrive Medical Device Consulting
Independent Consultant
Innoblative Designs, Inc. Oct 2014 - Dec 2017
Regulatory and Clinical Scientist
Surgical Innovation Associates Oct 2014 - Dec 2017
Preclinical and Regulatory Affairs
Medical College of Wisconsin Jun 2012 - Aug 2013
Research Fellow
Education:
Northwestern University 2014 - 2015
Master of Science, Masters, Biotechnology Milwaukee School of Engineering 2010 - 2014
Bachelors, Engineering
Skills:
Cell Culture
Pcr
Teamwork
Immunohistochemistry
Research
Cell Biology
Western Blotting
Public Speaking
U.s. Food and Drug Administration
Clinical Trials
Trials
Life Sciences
Medical Devices
Medical Surgical
Grant Writing
Communication
Product Development
Clinical Research
Data Analysis
Good Clinical Practice
Ce Marking
Iso 13485
Project Management
Microsoft Office
Microsoft Word
Microsoft Powerpoint
Microsoft Excel

Publications

Us Patents

Treatment Devices And Methods

View page
US Patent:
20190142508, May 16, 2019
Filed:
Sep 5, 2018
Appl. No.:
16/122111
Inventors:
- Chicago IL, US
Michelle Hasse - Eau Claire MI, US
Tyler Wanke - Chicago IL, US
International Classification:
A61B 18/14
Abstract:
The present invention is directed to a medical device for providing treatment to diseased tissue and cells. The medical device is configured to ablate a target tissue surface, optionally within a resection cavity, and further deliver a therapeutic that targets diseased (e.g., cancer) cells via a marker whose expression is upregulated by the ablation. The ablation directly kills diseased cells associated with the tissue surface. While some diseased cells evade direct ablation, those cells nevertheless upregulate certain cell surface markers in response to the ablation, even while other, healthy or normal cells do not upregulate expression of the marker in response to the ablation. Devices and methods disclosed herein are used to deliver a therapeutic that uses the upregulated cell surface marker to cause the death of those diseased cells.

Treatment Devices And Methods

View page
US Patent:
20180104004, Apr 19, 2018
Filed:
Oct 16, 2017
Appl. No.:
15/784778
Inventors:
- Chicago IL, US
Michelle Hasse - Eau Claire MI, US
Tyler Wanke - Chicago IL, US
International Classification:
A61B 18/14
Abstract:
The present invention is directed to a medical device for providing treatment to diseased tissue and cells. The medical device is configured to ablate a target tissue surface, optionally within a resection cavity, and further deliver a therapeutic that targets diseased (e.g., cancer) cells via a marker whose expression is upregulated by the ablation. The ablation directly kills diseased cells associated with the tissue surface. While some diseased cells evade direct ablation, those cells nevertheless upregulate certain cell surface markers in response to the ablation, even while other, healthy or normal cells do not upregulate expression of the marker in response to the ablation. Devices and methods disclosed herein are used to deliver a therapeutic that uses the upregulated cell surface marker to cause the death of those diseased cells.

Resecting And Coagulating Tissue

View page
US Patent:
20170252092, Sep 7, 2017
Filed:
Feb 24, 2017
Appl. No.:
15/442079
Inventors:
- Chicago IL, US
Tyler Wanke - Chicago IL, US
Ryan M. Bean - Westminster MA, US
Michelle Hasse - Eau Claire MI, US
International Classification:
A61B 18/14
Abstract:
The invention generally relates to a tissue ablation system including an ablation device to be delivered to a target site and achieve both resection and coagulation of tissue. The ablation device can be used during an electrosurgical resection procedure to both resect tissue and further selectively coagulate surrounding tissue in the resection site so as to prevent or stop fluid accumulation (e.g., blood from vessel(s)) as a result of the resection of tissue.

Cavitary Tissue Ablation System

View page
US Patent:
20170215947, Aug 3, 2017
Filed:
Jan 30, 2017
Appl. No.:
15/419269
Inventors:
- Chicago IL, US
Alyssa Bailey - Chicago IL, US
Ryan M. Bean - Westminster MA, US
Tyler Wanke - Chicago IL, US
Michelle Hasse - Eau Claire MI, US
International Classification:
A61B 18/14
Abstract:
The invention is a tissue ablation system including an ablation device having an electrode array configured for the ablation of tissue, wherein the electrode array includes a plurality of conductive wires electrically isolated and independent from one another and configured to receive electrical current from a source and emit radiofrequency (RF) energy in response. The ablation system further includes a controller configured to control an emission pattern from the electrode array, either by independently controlling activation of one or more conductive wires or by actively blocking emission of energy from a selected one or more conductive wires or by adjusting flow of a conductive fluid for carrying RF energy emitted in a virtual electrode arrangement. Accordingly, the system provides a user with custom ablation shaping including custom, user-defined ablation geometries or profiles for RF emission in a desired shape or pattern so as to deliver targeted treatment to marginal tissue.
Control profile
Michelle E Hasse from Elkhart, IN, age ~32 Get Report